Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses.
Nanayakkara N, Curtis AJ, Heritier S, Gadowski AM, Pavkov ME, Kenealy T, Owens DR, Thomas RL, Song S, Wong J, Chan JC, Luk AO, Penno G, Ji L, Mohan V, Amutha A, Romero-Aroca P, Gasevic D, Magliano DJ, Teede HJ, Chalmers J, Zoungas S.
Diabetologia. 2021 Feb;64(2):275-287. doi: 10.1007/s00125-020-05319-w. Epub 2020 Dec 14.
Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial.
Bonaca MP, Catarig AM, Houlind K, Ludvik B, Nordanstig J, Ramesh CK, Rasouli N, Sourij H, Videmark A, Verma S; STRIDE Trial Investigators.
Lancet. 2025 May 3;405(10489):1580-1593. doi: 10.1016/S0140-6736(25)00509-4. Epub 2025 Mar 29.
Preventing foot ulcers in patients with diabetes.
Singh N, Armstrong DG, Lipsky BA.
JAMA. 2005 Jan 12;293(2):217-28. doi: 10.1001/jama.293.2.217.
Limb and cardiovascular event risk in type 1 and 2 diabetic patients with peripheral artery disease.
Sykora D, Firth C, Girardo M, Tseng A, Wennberg P, Liedl D, Shamoun F.
Vasa. 2023 Sep;52(5):310-316. doi: 10.1024/0301-1526/a001086. Epub 2023 Jul 31.
Diabetic foot ulcer--A review on pathophysiology, classification and microbial etiology.
Noor S, Zubair M, Ahmad J.
Diabetes Metab Syndr. 2015 Jul-Sep;9(3):192-9. doi: 10.1016/j.dsx.2015.04.007. Epub 2015 Apr 29.
Risk factors for peripheral artery disease and diabetic peripheral neuropathy among patients with type 2 diabetes.
Chen T, Xiao S, Chen Z, Yang Y, Yang B, Liu N.
Diabetes Res Clin Pract. 2024 Jan;207:111079. doi: 10.1016/j.diabres.2023.111079. Epub 2023 Dec 26.
Association between plasma omentin-1 levels in type 2 diabetic patients and peripheral artery disease.
Biscetti F, Nardella E, Bonadia N, Angelini F, Pitocco D, Santoliquido A, Filipponi M, Landolfi R, Flex A.
Cardiovasc Diabetol. 2019 Jun 5;18(1):74. doi: 10.1186/s12933-019-0880-7.
Modifiable Lifestyle Factors, Genetic Risk, and Incident Peripheral Artery Disease Among Individuals With Type 2 Diabetes: A Prospective Study.
Zhu K, Qian F, Lu Q, Li R, Qiu Z, Li L, Li R, Yu H, Deng Y, Yang K, Pan A, Liu G.
Diabetes Care. 2024 Mar 1;47(3):435-443. doi: 10.2337/dc23-1503.
Peripheral arterial disease among children with type 1 diabetes mellitus in a Nigerian teaching hospital.
Akinyosoye G, Akinola IJ, Lamina AB, Akinsola CM.
J Pediatr Endocrinol Metab. 2023 Mar 21;36(4):378-383. doi: 10.1515/jpem-2022-0504. Print 2023 Apr 25.
Design and baseline characteristics of the STRIDE trial: evaluating semaglutide in people with symptomatic peripheral artery disease and type 2 diabetes.
Bonaca MP, Catarig AM, Hansen Y, Houlind K, Ramesh CK, Ludvik B, Nordanstig J, Rasouli N, Sourij H, Verma S.
Eur Heart J Cardiovasc Pharmacother. 2025 Jan 11;10(8):728-737. doi: 10.1093/ehjcvp/pvae071.
